Search Results
You are looking at 21 - 25 of 25 items for
- Author: R. M. Sharpe x
- Refine by access: All content x
Search for other papers by R. M. SHARPE in
Google Scholar
PubMed
Search for other papers by M. SHAHMANESH in
Google Scholar
PubMed
Search for other papers by M. G. ELLWOOD in
Google Scholar
PubMed
Search for other papers by M. HARTOG in
Google Scholar
PubMed
Search for other papers by P. S. BROWN in
Google Scholar
PubMed
SUMMARY
Anterior pituitary glands from male rats aged 21, 40, 60 or 95 days were incubated in medium containing 0, 2 or 20 ng luteinizing hormone-releasing hormone (LH-RH)/ml. Incubates were assayed for LH by radioimmunoassay (RIA), by the radioligand-receptor assay (RLA) using testicular homogenates as the source of receptor and, in some instances, by the ovarian ascorbic acid depletion assay (OAAD). Irrespective of the dose of added LH-RH, glands from rats aged 40 and 60 days always showed a higher release of LH, as determined by RLA, than glands from animals aged 21 or 95 days. Measurement by RIA showed a similar pattern to RLA in the basal release of LH, but in the presence of LH-RH showed little difference in LH release by glands from rats aged 40, 60 or 95 days. The LH release caused by the higher concentration of LH-RH was always greater when measured by RLA than by RIA. Assay of comparable incubates by OAAD showed close agreement with RLA estimates in four incubations (mean index of discrimination 1·07; range 0·86–1·18) and consistent disagreement with RIA estimates (1·64; range 1·38–1·99). In contrast to the results with incubates, homogenates of pituitary glands from male rats of various ages showed close agreement of estimates by RLA, RIA and OAAD. These results suggest that RIA underestimates the LH-RH-stimulated release of LH in vitro from the male rat pituitary during some stages of sexual maturation.
Search for other papers by A. S. McNEILLY in
Google Scholar
PubMed
Search for other papers by R. M. SHARPE in
Google Scholar
PubMed
Search for other papers by D. W. DAVIDSON in
Google Scholar
PubMed
Search for other papers by H. M. FRASER in
Google Scholar
PubMed
Pituitary glands were transplanted under the kidney capsule to induce hyperprolactinaemia in both immature (41 days old) and adult (150 days old) intact male rats. Blood samples were taken for hormone analysis at regular intervals after transplantation and the animals were killed 42–45 days after the operation.
Serum levels of prolactin rose in all groups of rats with transplants except in those animals bearing only one pituitary gland. Increased adrenal weight in all transplanted groups suggested that effective hyperprolactinaemia was always achieved. Serum levels of LH and FSH were significantly suppressed in all animals with transplants; the pituitary LH content was as reduced in all animals except those bearing one pituitary transplant but reductions in the pituitary FSH content were inconsistent. Although the amount of luteinizing hormone releasing hormone (LH-RH) in the hypothalamus did not differ significantly between groups, the effects of hyperprolactinaemia on serum and pituitary levels of LH and FSH suggested a functional lack of LH-RH (possibly due to an increase in the sensitivity of the hypothalamus to the negative feedback effects of testicular steroids).
Serum levels of testosterone remained normal in spite of reductions in the serum concentrations of LH and FSH and, in immature animals, a reduction in testicular binding of LH/human chorionic gonadotrophin.
These results are discussed in the light of previous conflicting reports on the effects of induced hyperprolactinaemia on the regulation of secretion of LH and FSH.
Search for other papers by A P West in
Google Scholar
PubMed
Search for other papers by C McKinnell in
Google Scholar
PubMed
Search for other papers by R M Sharpe in
Google Scholar
PubMed
Search for other papers by P T K Saunders in
Google Scholar
PubMed
Abstract
The aim of this study was to explore whether pituitary adenylate cyclase activating polypeptide (PACAP) could regulate protein synthesis by enriched preparations of spermatocytes and spermatids from the adult rat testis. Spermatocytes and spermatids were incubated for 8 h or 24 h in the absence (control) or presence of PACAP-27, PACAP-38, vasoactive intestinal peptide (VIP) or dibutyryl adenosine-3′,5′-cyclic monophosphate (db-cAMP). Total synthesis of intracellular and secreted proteins, during the incubation periods, was assessed and selected samples were analysed by 2-D SDS-PAGE. PACAP-38 (200 nm), VIP (200 nm) and db-cAMP (1 mm) significantly increased the synthesis of spermatocyte-secreted and intracellular proteins by 8 h and 24 h. Synthesis of both intracellular and secreted proteins by spermatids was significantly inhibited at 8 h and 24 h with PACAP, VIP and db-cAMP. The abundance of four germ cell-secreted proteins (GSP1, GSP2, GSP3 and phosphatidyethanolamine-binding protein (PEBP)), which can be identified in both spermatocyte and spermatid culture medium, and β-actin, which can only be identified in spermatid culture medium, was analysed. PACAP-38 and db-cAMP significantly increased the incorporation of label into GSP1, GSP2, GSP3 and PEBP, derived from spermatocyte culture medium, at 8 h and 24 h. In contrast PACAP-38 inhibited the incorporation of label into GSP1 and β-actin, derived from spermatid culture medium, at 24 h. The results show that PACAP can regulate synthesis of both secreted and intracellular proteins by spermatids and spermatocytes in vitro. This effect is mimicked with high doses of db-cAMP (>1 mm), suggesting that PACAP may act via a pathway that involves changes in cyclic AMP concentration in the germ cells.
Journal of Endocrinology (1995) 144, 215–223
Search for other papers by R. M. Sharpe in
Google Scholar
PubMed
Search for other papers by I. A. Swanston in
Google Scholar
PubMed
Search for other papers by I. Cooper in
Google Scholar
PubMed
Search for other papers by C. G. Tsonis in
Google Scholar
PubMed
Search for other papers by A. S. McNeilly in
Google Scholar
PubMed
ABSTRACT
Immunoreactive inhibin was measured in testicular interstitial fluid (IF) from rats during sexual maturation or after impairment of spermatogenesis induced by ethane dimethanesulphonate (EDS), unilateral cryptorchidism or local heating (43 °C, 30 min) of the testes, to ascertain its usefulness as a marker of changing Sertoli cell function. Cultures of isolated seminiferous tubules were also studied. Inhibin was measured by a radioimmunoassay directed towards the first 26 amino acids of the N-terminus of the α-subunit, and the results confirmed for selected pools of IF by in-vitro bioassay using dispersed ovine pituitary cells.
During puberty, IF levels of immunoactive inhibin fell by more than 90% (P<0·001) between 30 and 60 days of age, a decrease paralleled by the levels of androgen-binding protein (ABP), another Sertoli cell product secreted into IF. These changes also paralleled, but preceded, the fall (60%; P<0·001) in serum levels of FSH between 40 and 70 days, while the serum and IF levels of testosterone increased more than two-fold over this period. When adult rats were injected with EDS to destroy the Leydig cells, testosterone levels in IF and serum were undetectable at 3 and 7 days after treatment, were just detectable at 14 days and thereafter returned slowly towards normal by 42 days. The initial androgen withdrawal following EDS treatment caused a progressive reduction in testicular weight up to 21 days and this was accompanied by a significant increase in the serum levels of FSH and a two- to threefold increase in the IF levels of immunoactive inhibin (and also of ABP). Serum FSH and IF levels of immunoactive inhibin returned to within the normal range by 42 days when testosterone levels had normalized. In contrast, in two other experimental situations in which a marked decrease in testicular weight coupled with an increase in IF levels of ABP occurs, different results for the IF levels of immunoactive inhibin were obtained. Thus, in rats exposed to local heating of the testes, IF levels of immunoactive inhibin remained unchanged from control values at 21–40 days after treatment, a finding confirmed by bioassay results. In rats made unilaterally cryptorchid for 10 months, levels of immunoactive inhibin in IF were reduced by 60% (P<0·01) in the abdominal compared with the contralateral scrotal testis.
These results suggest that (1) IF levels of immunoactive inhibin do not always change in parallel to the levels of ABP and may be a useful marker of changing Sertoli cell function, and (2) in at least two situations (puberty and after EDS treatment), there may be a positive relationship between the serum levels of FSH and the IF levels of immunoactive inhibin. This positive relationship was confirmed by in-vitro findings in which FSH and dibutyryl cyclic AMP (but not testosterone) were shown to stimulate immunoactive inhibin production by isolated rat seminiferous tubules during culture for 2–6 days.
J. Endocr. (1988) 119, 315–326
Search for other papers by J S Fisher in
Google Scholar
PubMed
Search for other papers by M R Millar in
Google Scholar
PubMed
Search for other papers by G Majdic in
Google Scholar
PubMed
Search for other papers by P T K Saunders in
Google Scholar
PubMed
Search for other papers by H M Fraser in
Google Scholar
PubMed
Search for other papers by R M Sharpe in
Google Scholar
PubMed
Abstract
The sites of action and the physiological role of oestrogens in the male reproductive tract are poorly understood. We have undertaken a systematic study of the immunoexpression of oestrogen receptor-α (ERα) in the male rat from late fetal life through to adulthood and compared the findings with results obtained in the marmoset monkey (Callithrix jacchus) from neonatal to adult life. The testes, rete testis, efferent ducts and epididymis were examined from normal male rats (aged 4, 8, 10, 15, 20, 25, 38, 48 and 90 days) and from male rat fetuses on days 17·5 and 18·5 of gestation; comparable tissues were examined from neonatal, infantile, peripubertal and adult marmosets aged 8, 18–24, 54–62 and 92–112 weeks respectively. Immunolocalisation of ERa used antigen retrieval and a monoclonal antibody directed to the N-terminus, which had proved superior to six other antisera tested. ERa was immunoexpressed in interstitial cells, including the fetal/neonatal generation of Leydig cells, in both the rat and marmoset. In the rat, the adult generation of Leydig cells were also immunopositive for ERa whereas the comparable cells in the marmoset were only weakly immunopositive. ERa was not expressed in Sertoli cells, peritubular myoid cells, blood vessels or germ cells at any time in either species. In late fetal life in the rat, ERa was immunoexpressed in cells surrounding the mesonephric tubules, whereas postnatally it was expressed in the epithelium of the rete testis and efferent ducts at all ages from 4 to 90 days; this immunoexpression was most pronounced in the efferent ducts. In the marmoset, the efferent ducts, but not the rete testis, also showed intense immunoexpression of ERa. Apart from sporadic immunostaining for ERa in the epididymal duct of the rat in the neonatal period, the caput, corpus and cauda epididymis were negative for immunoexpression of ERa at all ages in both species. These findings suggest that the main actions of oestrogens in the male reproductive tract, mediated by ERa, are related to the development and function of the efferent ducts and the Leydig cells. In consideration of data from this and previous studies of oestrogen binding, we predict possible sites of expression of other oestrogen receptors (e.g. ERβ) in Sertoli cells and the epididymis. Interactive effects, related to the relative levels of androgens and oestrogens, could be physiologically important in the excurrent ducts of the adult testis.
Journal of Endocrinology (1997) 153, 485–495